Collegium Pharmaceutical Gains Momentum on Jornay PM, Truist Highlights Robust Pain Portfolio

Collegium Pharmaceutical is experiencing increased momentum, driven by its product Jornay PM, with Truist analysts highlighting the company's strong pain portfolio.